Nivolumab for unresectable cutaneous epithelial malignancies: an open-label, single-arm, multi-centre, phase II trial (NMSC-PD1).
Saved in:
| Title: | Nivolumab for unresectable cutaneous epithelial malignancies: an open-label, single-arm, multi-centre, phase II trial (NMSC-PD1). |
|---|---|
| Authors: | Nakamura Y; Department of Dermatology, Keio University School of Medicine, Tokyo, Japan., Yamazaki N; Department of Dermatologic Oncology, National Cancer Centre Hospital, Tokyo, Japan., Namikawa K; Department of Dermatologic Oncology, National Cancer Centre Hospital, Tokyo, Japan., Uchi H; Department of Dermato-Oncology, National Hospital Organisation Kyushu Cancer Centre, Fukuoka, Japan., Mori S; Department of Dermatology, Nagoya University Graduate School of Medicine, Aichi, Japan., Ogawa-Momohara M; Department of Dermatology, Nagoya University Graduate School of Medicine, Aichi, Japan., Fujimura T; Department of Dermatology, Tohoku University School of Medicine, Miyagi, Japan., Takenouchi T; Division of Dermatology, Niigata Cancer Centre Hospital, Niigata, Japan., Kurimoto M; Department of Dermatology, Wakayama Medical University, Wakayama, Japan., Yamamoto Y; Department of Dermatology, Wakayama Medical University, Wakayama, Japan., Otsuka A; Department of Dermatology, Kyoto University School of Medicine, Kyoto, Japan., Kabashima K; Department of Dermatology, Kyoto University School of Medicine, Kyoto, Japan., Fusumae T; Department of Dermatology, Keio University School of Medicine, Tokyo, Japan., Hirai I; Department of Dermatology, Keio University School of Medicine, Tokyo, Japan., Tanese K; Department of Dermatology, Keio University School of Medicine, Tokyo, Japan.; Department of Dermatology, Toho University School of Medicine, Tokyo, Japan., Saito Y; Department of Dermatology, Keio University School of Medicine, Tokyo, Japan., Amagai M; Department of Dermatology, Keio University School of Medicine, Tokyo, Japan., Takemura R; Department of Preventive Medicine and Public Health, Biostatistics Unit at Clinical Translational Research Centre, Keio University School of Medicine, Tokyo, Japan., Sato Y; Department of Preventive Medicine and Public Health, Biostatistics Unit at Clinical Translational Research Centre, Keio University School of Medicine, Tokyo, Japan., Funakoshi T; Department of Dermatology, Keio University School of Medicine, Tokyo, Japan. takeruf@keio.jp. |
| Source: | BMC cancer [BMC Cancer] 2026 Mar 04; Vol. 26 (1). Date of Electronic Publication: 2026 Mar 04. |
| Publication Type: | Journal Article; Clinical Trial, Phase II; Multicenter Study |
| Journal Info: | Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
